EU Market Entry Strategy for North American Brands: Step-by-Step

Every year, dozens of North American supplement, cosmetic, and pharmaceutical brands attempt to enter the EU market. A significant proportion of them underestimate the regulatory complexity, overestimate the speed of the process, and run out of runway before they achieve meaningful EU revenue. The brands that succeed are those that approach EU market entry as a strategic programme — not a compliance checkbox exercise.

This guide outlines the strategic framework we use at Care Europe when advising North American brands on EU market entry.

Why EU Market Entry Fails

Before the strategy, the failure modes. Understanding why EU market entry fails helps you avoid the most common mistakes.

Regulatory underestimation: Brands assume EU compliance is similar to US compliance — a notification here, a label change there. In reality, the EU framework is fundamentally different in its approach (positive lists vs. presumption of safety), its claims framework (authorised claims only vs. structure/function claims), and its enforcement culture (proactive market surveillance vs. reactive FDA enforcement).

Timeline underestimation: Brands plan for a 3-month EU launch and discover that ingredient compliance review, label development, DGCCRF notification, and distributor onboarding take 12 to 18 months. Products miss their planned launch windows, and the business case deteriorates.

Reformulation surprise: Brands discover after committing to EU market entry that their hero product contains ingredients that are not on the EU positive list, require Novel Food authorisation, or have restricted claims. Reformulation adds 6 to 18 months and significant cost.

Distributor dependency: Brands sign with an EU distributor who promises to handle all regulatory compliance. The distributor does not have the regulatory expertise to do so, compliance gaps accumulate, and the brand faces market surveillance action.

Claims mismatch: Brands use their US marketing materials in the EU, including claims that are not authorised under Regulation (EC) No 1924/2006. Competitors or market surveillance authorities flag the non-compliant claims, triggering enforcement action.

The Strategic Framework: Four Phases

Phase 1: Market and Regulatory Assessment (Months 1-3)

Before committing resources to EU market entry, conduct a thorough assessment:

Market assessment:

• Which EU markets offer the best opportunity for your product category? (France, Germany, UK, Italy, and Spain are the five largest markets)
• What is the competitive landscape in your category?
• What are the distribution channels — specialty retail, pharmacy, e-commerce, direct-to-consumer?
• What price points are sustainable given EU regulatory compliance costs?

Regulatory assessment:

• Ingredient compliance audit: every ingredient against EU positive lists, Novel Food requirements, and national botanical lists
• Claims audit: every claim against the EU Register of authorised health claims
• Labeling gap analysis: what changes are required for EU-compliant labels?
• Novel Food assessment: are any ingredients Novel Foods requiring authorisation?
• Reformulation assessment: if reformulation is required, what is the timeline and cost?

Output of Phase 1: A regulatory gap analysis document that identifies every compliance gap, the action required to close it, the timeline, and the estimated cost. This document is the foundation of your EU market entry business case.

Phase 2: Regulatory Compliance Development (Months 3-12)

Based on the Phase 1 assessment, develop the compliance package:

Reformulation (if required): Work with your formulation team to develop EU-compliant formulas. This may involve replacing ingredients not on EU positive lists, adjusting concentrations to comply with maximum levels, or removing ingredients with uncertain Novel Food status.

Label development: Develop EU-compliant labels for each target market. This includes:

• Redesigning the label format (no Supplement Facts panel)
• Calculating EU NRV percentages
• Selecting authorised health claims
• Translating into target market languages
• Including all mandatory warnings and statements

Responsible Person / EU importer appointment: Identify and appoint an EU-established entity to act as your importer and take on EU compliance responsibility. This entity’s name and address will appear on your product label.

GMP compliance: Ensure your manufacturing site meets EU food safety GMP requirements. If you plan to target France specifically, ensure your manufacturing site can provide the documentation required for DGCCRF notification.

DGCCRF notification (for France): Submit the pre-market notification to DGCCRF. Allow 2 to 4 months for the notification process.

Phase 3: Market Entry (Months 12-18)

With compliance in place, execute the market entry:

Distributor selection: Select EU distributors with specific experience in your product category and target markets. Evaluate their regulatory knowledge, their existing retail relationships, and their track record with North American brands.

E-commerce setup: EU e-commerce requires compliance with EU consumer protection law, GDPR (data protection), and VAT registration in each country where you have significant sales. These are separate compliance requirements from product compliance.

Launch markets: Start with one or two EU markets rather than attempting a pan-EU launch. France and Germany are the most common first markets for supplement brands due to their size and established supplement retail infrastructure.

Pricing strategy: EU supplement prices are typically lower than US prices for equivalent products. Factor in regulatory compliance costs, import duties (0% for most supplements from the US under TTIP-equivalent arrangements), and distributor margins when setting EU prices.

Phase 4: Growth and Compliance Maintenance (Ongoing)

EU market presence requires ongoing compliance maintenance:

Regulatory monitoring: EU supplement regulations change. New substances are added to Novel Food lists, health claim applications are evaluated, and national regulations are updated. Establish a monitoring programme to track relevant regulatory developments.

Label updates: When regulations change, labels must be updated. Build a label update process into your EU operations.

Market surveillance response: EU market surveillance authorities conduct product testing and compliance checks. If your product is tested and found non-compliant, you need a rapid response capability. Ensure your EU importer has a documented response process.

Expansion to additional markets: Once established in your launch markets, expand to additional EU markets using the compliance infrastructure you’ve built.

Timeline and Budget Summary

Phase	Timeline	Estimated Budget
Phase 1: Assessment	Months 1-3	€5,000–€20,000
Phase 2: Compliance development	Months 3-12	€30,000–€100,000
Phase 3: Market entry	Months 12-18	€20,000–€50,000
Phase 4: Ongoing maintenance	Annual	€10,000–€30,000/year
Total Year 1	12-18 months	€55,000–€170,000

These estimates cover regulatory compliance costs. They do not include product inventory, marketing, distribution costs, or the cost of reformulation if required.

Choosing Your First EU Market

For most North American supplement and cosmetic brands, France is the recommended first EU market:

• Size: France is the second-largest EU supplement market (after Germany) and the largest EU cosmetics market
• Regulatory clarity: DGCCRF notification provides a defined regulatory pathway with clear requirements
• Distribution infrastructure: France has a well-developed specialty health retail sector (pharmacies, parapharmacies, health food stores) and strong e-commerce
• Care Europe presence: As a French-based regulatory consultancy, we have direct relationships with DGCCRF and French distribution partners

Germany is the alternative first market for brands targeting the German-speaking market or with existing German distribution relationships.

At Care Europe, we develop and execute EU market entry strategies for North American supplement, cosmetic, and nutraceutical brands. Contact us at [email protected] to discuss your specific situation.